Aspen Pharmacare said it had reached a €25m settlement in a contractual dispute with a client over a manufacturing and ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

Demonstrated feasibility of effective DNA delivery with Company's xPhore nanoparticle technologyDNA delivery technology to be offered as GenePhore to biotech / pharma companiesAddressing large and gro ...

Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise.

Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the ...